Two drugs can help obese patients without diabetes to lose weight

Two drugs can help obese patients without diabetes to lose weight

March 28, 2017 Source: Bio Valley

Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];

According to WHO data, more than 1.4 billion people over the age of 20 and over are overweight, more than 200 million men and nearly 300 million women are obese; the United States ranks first with 78 million obese people, followed by It is China and India, with obesity populations of 46 million and 30 million respectively. In 2010, the US Centers for Disease Control and Prevention announced that obese adults in the United States accounted for 35.7% of the total population. In 2002-2010, the proportion of overweight and obesity in Chinese adults rose from 25% to 38.5%, with urban residents accounting for the majority. It is understood that the obese population under the age of 18 in China has reached 120 million. How to prevent and treat obesity has become a very serious scientific problem.

A recent study published in the international academic journal Diabetes Care showed that for obese or overweight individuals without type 2 diabetes, the simultaneous use of the SGLT2 inhibitor canagliflozin and the appetite suppressant phentermine may have significant weight loss effects. And can be well tolerated.

Dr. Priscilla Hollander of the Baylor University Medical Center and his colleagues tested the efficacy and safety of concurrent administration of both CANA and PHEN in a randomized clinical trial involving 335 patients without type 2 diabetes. Obese or overweight participants also had a placebo group and a CANA and PHEN monotherapy group. Participants were randomized to receive placebo, CANA, PHEN, or CANA/PHEN medication once daily.

The researchers found that in the 26th week compared with the placebo group, the CANA/PHEN simultaneous administration group had a more pronounced weight loss effect, with weight loss exceeding 5% and systolic blood pressure also decreasing. In addition, CANA/PHEN is well tolerated and has good safety and tolerability compared to the drug group alone.

"CANA/PHEN is a drug that delivers significant weight loss and is resistant to overweight or obese individuals without type 2 diabetes," the authors write. “There is a need for further research in the future to assess the potential use of this combination of drugs for long-term management of body weight.”

Some authors have revealed that they have established contacts with a number of drug companies, including Janseen, which has worked with Mitsubishi Tanabe Pharmaceuticals of Japan to develop canagliflozin.

Whole(Multi)Black Garlic

Whole ( Multi bulb ) Black Garlic is made of the whole fresh white garlic .

It appears black in colour and shrinks during the fermenting process.

The cloves varies in diameter between 5.0 - 6.0cm and weights in at 30-40g before being peeled.

Black Garlic Production Process

Fresh organic garlic → Cleaning → Dehydration → Clip → Outfit fermentation dish → Fermentation room → Fermentation → Booth cool room → Ripen → Sterilization room → Black garlic sorting room → Inner packing → Outer packing → Black garlic storeroom



Whole Black Garlic

Whole Black Garlic,Whole Foods Black Garlic,Multi Bulb Black Garlic,Fermented Whole Black Garlic

Zhucheng Tongxi Commercial And Trade Co.,Ltd. , https://www.blackgarlicgroup.com